HOUSTON, Texas -- New Jersey-based pharmaceutical giant Bristol Myers Squibb Co. has officially named Houston as the home of its new state-of-the-art manufacturing site.
The 60,000-square-foot facility represents a $2.3 billion investment, according to a news release. It is expected to create 500 skilled jobs and will be located in Houston's Generation Park.
BMS first announced that it was considering Houston among 16 other cities for the facility in May. The new hub will manufacture small-molecule, biologic, and antibody-drug conjugates and is part of a $40 billion commitment to invest in the United States over five years. Construction is slated to begin next year, with the facility coming online in 2030.
For more on this story, visit our partners at Culturemap.